BIOAGE LABS Funding: $300M Raised, Series D (2024)
BIOAGE LABS is a Biotech company based in Richmond, California. It has raised $300M in total funding. Latest round: Series D.
BIOAGE LABS funding overview
BIOAGE LABS is a Biotech company based in Richmond, California. BIOAGE LABS has raised $300M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in February 2024. The round record for BIOAGE LABS runs through 2024; nothing later has been disclosed. Investors on record include Andreessen Horowitz, Sofinnova Investments, Kaiser Permanente Ventures, Pear VC. 4 distinct backers are named across the disclosed rounds.
BIOAGE LABS at a glance
Total raised
$300M
Latest round
Series D
Latest round date
February 2024
Industry
Biotech
Headquarters
Richmond, California
Notable investors
Andreessen Horowitz, Sofinnova Investments, Kaiser Permanente Ventures, Pear VC
Frequently asked about BIOAGE LABS funding
How much has BIOAGE LABS raised?
BIOAGE LABS has raised $300M in total disclosed funding across the rounds on record.
Who has invested in BIOAGE LABS?
Andreessen Horowitz, Sofinnova Investments, Kaiser Permanente Ventures, Pear VC are named among the investors backing BIOAGE LABS.
What was the latest BIOAGE LABS funding round?
The most recent disclosed round is a Series D, announced in February 2024.
Where is BIOAGE LABS based?
BIOAGE LABS is based in Richmond, California.
What sector does BIOAGE LABS operate in?
BIOAGE LABS is tracked under Biotech from Richmond, California, with $300M in disclosed funding.
When did BIOAGE LABS last raise?
The last disclosed BIOAGE LABS round closed in February 2024 at Series D.
Totals shown for BIOAGE LABS aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Richmond and the investors behind them below.
